FDA Inspection 1235713 — AeroBiotix USA

AeroBiotix USA — FEI 3014151865

The FDA completed an inspection of AeroBiotix USA on Apr 11, 2024 in Miamisburg, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 11, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Miamisburg, OH (United States)

Citations

IDCFRDescription
313021 CFR 820.100(a)Lack of or inadequate procedures
317221 CFR 820.198(c)Investigation of device failures
368621 CFR 820.90(b)(2)Product rework documentation, DHR {see also 820.184}

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.